From Insights to Action: Lessons from the BCI Crisis Management Report 2024
To register for this event please log in to your BCI website profile.If you do not have a website profile, please register here. Please note that this event is for BCI Members only and that by registering for a BCI website profile you are not applying for a BCI Membership.
Join Markus Epner, Head of Academy at F24 and an experienced crisis management expert, for an engaging webinar that critically examines the findings of the BCI Crisis Management Report 2024. This session explores key trends, challenges, and opportunities in crisis management practices. Beyond actionable insights, the webinar addresses how socially desirable misstatements may have shaped the report—helping you refine your resilience strategies for 2025.
Key Takeaways:
- Survey Results: Gain insights into how organisations are approaching crisis management, including the evolving role of technology and emerging best practices.
- Technology vs. Tradition: Understand why many organisations acknowledge the value of advanced technology but still rely on traditional methods like call trees.
- Best Practices for 2025: Discover actionable recommendations and forward-looking strategies to enhance your organisation’s crisis management approach.
Speakers:
-
Maria Florencia Lombardero Garcia
Thought Leadership Manager, BCI
-
Rachael Elliott
Knowledge Strategist, BCI
-
Markus Epner
Head of Academy, F24
Markus worked in several positions in different security and crisis teams, was one of the first officers in the Kommando Spezialkräfte and his experience from the Bosnian and Kosovo wars as well as his many years of leadership experience in industry gave him confidence when acting in critical events.
He studied Security and Crisis Management in Kiel and has more than 20 years of experience in security and crisis management with Lufthansa and Boehringer Ingelheim. During his time in the industry he managed, beside some other crisis, the evacuation of two crews out of Mumbai during the terror attacks and the covid-19 crisis during his time in the pharmaceutical industry.
More on
